CoChat

Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial

Chaitman, Bernard R., Rosen, Allan D., Williams, David O., Bourassa, Martial G., Aguirre, Frank V., Pitt, Bertram, Rautaharju, Pentti M., Rogers, William J., Sharaf, Barry, Attubato, Michael, Hardison, Regina M., Srivatsa, Sanjay, Kouchoukos, Nicholas T., Stocke, Karen, Sopko, George, Detre, Katherine, Frye, Robert · 1997 · Circulation
Cited by 130

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background Cardiac mortality and myocardial infarction (MI) rates are used to evaluate the efficacy of coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA). We compared 5-year cardiac mortality and MI rates in 1829 patients with multivessel disease randomized to CABG or PTCA. Methods and Results The 5-year cardiac mortality rate was 8.0% in patients assigned to PTCA compared with 4.9% in those assigned to CABG (relative risk [RR] of 1.55 with a 95% confidence interval [CI] of 1.07 to 2.23; P =.022). In a subgroup of 1476 nondiabetic patients, there were no significant differences between treatment groups in cardiac mortality either overall (4.6% versus 4.2%; RR=1.04, 95% CI, 0.65 to 1.66; P =.908) or in subgroups based on symptoms, left ventricular function, number of diseased vessels, or stenotic proximal left anterior descending artery. The two treatment groups had similar event rates for the combined end point of cardiac death or MI. The RR for cardiac mortality in 264 patients who sustained an MI compared with those who did not was 5.9 ( P <.001). MIs were more common after CABG during index hospitalization ( P =.004), but in the PTCA group, they were more common after discharge ( P <.001). Conclusions The Bypass Angioplasty Revascularization Investigation (BARI) trial indicates 5-year cardiac mortality in patients with multivessel disease was significantly greater after initial treatment with PTCA than with CABG. The difference was manifest in diabetic patients on drug therapy. There were no significant differences overall for the composite end point of cardiac mortality or MI between treatment groups or for cardiac mortality in nondiabetic patients regardless of symptoms, left ventricular function, number of diseased vessels, or stenotic proximal left anterior descending artery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.96.7.2162

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 130

Metadata

Authors
Chaitman, B. R., Rosen, A. D., Williams, D. O., Bourassa, M. G., Aguirre, F. V., Pitt, B., Rautaharju, P. M., Rogers, W. J., Sharaf, B., Attubato, M., Hardison, R. M., Srivatsa, S., Kouchoukos, N. T., Stocke, K., Sopko, G., Detre, K., & Frye, R.
Venue
Circulation
Published
1997-10-07
Volume
96
Issue
7
Pages
2162-2170
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2057061197
Cited by
130
References
1
FWCI
9.24
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial. https://app.cochat.ai/papers/10.1161/01.cir.96.7.2162
The paper
Chaitman, B. R., Rosen, A. D., Williams, D. O., Bourassa, M. G., Aguirre, F. V., Pitt, B., Rautaharju, P. M., Rogers, W. J., Sharaf, B., Attubato, M., Hardison, R. M., Srivatsa, S., Kouchoukos, N. T., Stocke, K., Sopko, G., Detre, K., & Frye, R. (1997). Myocardial Infarction and Cardiac Mortality in the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial. Circulation. https://doi.org/10.1161/01.cir.96.7.2162

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.